Cargando…
CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
The molecular mechanisms underlying estrogen receptor (ER)‐positive breast carcinogenesis and endocrine therapy resistance remain incompletely understood. Here, we report that circPVT1, a circular RNA generated from the lncRNA PVT1, is highly expressed in ERα‐positive breast cancer cell lines and tu...
Autores principales: | Yi, Jia, Wang, Lei, Hu, Guo‐sheng, Zhang, Yue‐ying, Du, Jiao, Ding, Jian‐cheng, Ji, Xiang, Shen, Hai‐feng, Huang, Hai‐hua, Ye, Feng, Liu, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183818/ https://www.ncbi.nlm.nih.gov/pubmed/37009655 http://dx.doi.org/10.15252/embj.2022112408 |
Ejemplares similares
-
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
por: Wu, Tingrui, et al.
Publicado: (2022) -
A Concise Review on the Role of CircPVT1 in Tumorigenesis, Drug Sensitivity, and Cancer Prognosis
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021) -
Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps
por: RezaSoltani, Mahsa, et al.
Publicado: (2023) -
Prognostic and clinicopathological value of circPVT1 in human cancers: A meta‐analysis
por: Lin, Zhengjun, et al.
Publicado: (2021) -
Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma
por: Zhong, Rongrong, et al.
Publicado: (2019)